{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:59:10Z","timestamp":1780754350860,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":53,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_25","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:00:38Z","timestamp":1753707638000},"page":"381-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre-mRNA Splicing Modulation by Antisense Oligonucleotides"],"prefix":"10.1007","author":[{"given":"Natalia N.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra N.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"25_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","volume":"136","author":"MC Wahl","year":"2009","unstructured":"Wahl MC, Will CL, Luhrmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701\u2013718","journal-title":"Cell"},{"key":"25_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1261\/rna.876308","volume":"14","author":"Z Wang","year":"2008","unstructured":"Wang Z, Burge CB (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14:802\u2013813","journal-title":"RNA"},{"key":"25_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1101\/gr.119628.110","volume":"21","author":"S Ke","year":"2011","unstructured":"Ke S, Shang S, Kalachikov SM, Morozova I, Yu L, Russo JJ, Ju J, Chasin LA (2011) Quantitative evaluation of all hexamers as exonic splicing elements. Genome Res 21:1360\u20131374","journal-title":"Genome Res"},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"D118","DOI":"10.1093\/nar\/gks969","volume":"41","author":"A Busch","year":"2012","unstructured":"Busch A, Hertel KJ (2012) HEXEvent: a database of human EXon splicing events. Nucleic Acids Res 41:D118\u2013D124","journal-title":"Nucleic Acids Res"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/nar\/gkl1050","volume":"35","author":"NN Singh","year":"2007","unstructured":"Singh NN, Singh RN, Androphy EJ (2007) Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res 35:371\u2013389","journal-title":"Nucleic Acids Res"},{"key":"25_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.tibs.2009.10.004","volume":"35","author":"MB Warf","year":"2010","unstructured":"Warf MB, Berglund JA (2010) Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci 35:169\u2013178","journal-title":"Trends Biochem Sci"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.gde.2011.04.001","volume":"21","author":"CJ McManus","year":"2011","unstructured":"McManus CJ, Graveley BR (2011) RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev 21:373\u2013379","journal-title":"Curr Opin Genet Dev"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.jmb.2016.04.017","volume":"428","author":"T Saldi","year":"2016","unstructured":"Saldi T, Cortazar MA, Sheridan RM, Bentley DL (2016) Coupling of RNA polymerase II transcription elongation with pre-mRNA splicing. J Mol Biol 428:2623\u20132635","journal-title":"J Mol Biol"},{"key":"25_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrm.2017.63","volume":"9","author":"L Herzel","year":"2017","unstructured":"Herzel L, Ottoz DSM, Alpert T, Neugebauer KM (2017) Splicing and transcription touch base: co-transcriptional spliceosome assembly and function. Nat Rev Mol Cell Biol 9:637. https:\/\/doi.org\/10.1038\/nrm.2017.63","journal-title":"Nat Rev Mol Cell Biol"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ceb.2012.03.005","volume":"24","author":"M Irimia","year":"2012","unstructured":"Irimia M, Blencowe BJ (2012) Alternative splicing: decoding an expansive regulatory layer. Curr Opin Cell Biol 24:323\u2013332","journal-title":"Curr Opin Cell Biol"},{"key":"25_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.molcel.2017.01.011","volume":"65","author":"H Han","year":"2017","unstructured":"Han H, Braunschweig U, Gonatopoulos-Pournatzis T, Weatheritt RJ et al (2017) Multilayered control of alternative splicing regulatory networks by transcription factors. Mol Cell 65:539\u2013553","journal-title":"Mol Cell"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1261\/rna.7580704","volume":"10","author":"NN Singh","year":"2004","unstructured":"Singh NN, Androphy EJ, Singh RN (2004) In vivo selection reveals features of combinatorial control that defines a critical exon in the spinal muscular atrophy genes. RNA 10:1291\u20131305","journal-title":"RNA"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333\u20131346","journal-title":"Mol Cell Biol"},{"key":"25_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4161\/rna.6.3.8723","volume":"6","author":"NN Singh","year":"2009","unstructured":"Singh NN, Shishimorova M, Cao LC, Gangwani L, Singh RN (2009) A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol 6:341\u2013350","journal-title":"RNA Biol"},{"key":"25_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1261\/rna.2154310","volume":"16","author":"NN Singh","year":"2010","unstructured":"Singh NN, Hollinger K, Bhattacharya D, Singh RN (2010) An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing. RNA 16:1167\u20131181","journal-title":"RNA"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1093\/nar\/gkt609","volume":"41","author":"NN Singh","year":"2013","unstructured":"Singh NN, Lawler MN, Ottesen EW, Upreti D, Kaczynski JR, Singh RN (2013) An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy. Nucleic Acids Res 41:8144\u20138165","journal-title":"Nucleic Acids Res"},{"key":"25_CR17","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.2741\/2812","volume":"13","author":"AS Solis","year":"2008","unstructured":"Solis AS, Shariat N, Patton JG (2008) Splicing fidelity, enhancers, and disease. Front Biosci 13:1926\u20131942","journal-title":"Front Biosci"},{"key":"25_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnsyn.2011.00001","volume":"3","author":"RM Smith","year":"2011","unstructured":"Smith RM, Sadee W (2011) Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Front Synaptic Neurosci 3:1\u20138","journal-title":"Front Synaptic Neurosci"},{"key":"25_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.molmed.2012.06.006","volume":"18","author":"RK Singh","year":"2012","unstructured":"Singh RK, Cooper TA (2012) Pre-mRNA splicing in disease and therapeutics. Trends Mol Med 18:472\u2013482","journal-title":"Trends Mol Med"},{"key":"25_CR20","first-page":"2675","volume":"6","author":"MA Lewandowska","year":"2013","unstructured":"Lewandowska MA (2013) The missing puzzle piece: splicing mutations. Int J Clin Exp Pathol 6:2675\u20132682","journal-title":"Int J Clin Exp Pathol"},{"key":"25_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.4337","volume":"233","author":"S Pedrotti","year":"2014","unstructured":"Pedrotti S, Cooper TA (2014) In brief: (mis)splicing in disease. J Pathol 233:1\u20133","journal-title":"J Pathol"},{"key":"25_CR22","first-page":"893","volume":"5","author":"AM Fredericks","year":"2015","unstructured":"Fredericks AM, Cygan KJ, Brown BA, Fairbrother WG (2015) RNA-binding proteins: splicing factors and disease. Biomol Ther 5:893\u2013909","journal-title":"Biomol Ther"},{"key":"25_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/CS20160211","volume":"131","author":"D Baralle","year":"2017","unstructured":"Baralle D, Buratti E (2017) RNA splicing in human disease and in the clinic. Clin Sci (Lond) 131:355\u2013368","journal-title":"Clin Sci (Lond)"},{"key":"25_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000450650","volume":"92","author":"FA Luz","year":"2017","unstructured":"Luz FA, Br\u00edgido PC, Moraes AS, Silva MJ (2017) Aberrant splicing in cancer: mediators of malignant progression through an imperfect splice program shift. Oncology 92:3\u201313","journal-title":"Oncology"},{"key":"25_CR25","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/gb-2013-14-12-r143","volume":"14","author":"EF C\u00e1ceres","year":"2013","unstructured":"C\u00e1ceres EF, Hurst LD (2013) The evolution, impact properties of exonic splice enhancers. Genome Biol 14:R143","journal-title":"Genome Biol"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/ng.3837","volume":"49","author":"R Soemedi","year":"2017","unstructured":"Soemedi R, Cygan KJ, Rhine CL, Wang J, Bulacan C, Yang J, Bayrak-Toydemir P et al (2017) Pathogenic variants that alter protein code often disrupt splicing. Nat Genet 49:848\u2013855","journal-title":"Nat Genet"},{"key":"25_CR27","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1073\/pnas.1101135108","volume":"108","author":"KH Lim","year":"2011","unstructured":"Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG (2011) Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci USA 108:11093\u201311098","journal-title":"Proc Natl Acad Sci USA"},{"key":"25_CR28","first-page":"1563","volume":"21","author":"T Sterne-Weiler","year":"2011","unstructured":"Sterne-Weiler T, Howard J, Mort M, Cooper DN, Sanford JR (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome 21:1563\u20131571","journal-title":"Genome"},{"key":"25_CR29","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2012.02.014","volume":"148","author":"P Spitali","year":"2012","unstructured":"Spitali P, Aartsma-Rus A (2012) Splice modulating therapies for human disease. Cell 148:1085\u20131088","journal-title":"Cell"},{"key":"25_CR30","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44:6549\u20136563","journal-title":"Nucleic Acids Res"},{"key":"25_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","volume":"46","author":"JA Markowitz","year":"2012","unstructured":"Markowitz JA, Singh P, Darras BT (2012) Spinal muscular atrophy: a clinical and research update. Pediatr Neurol 46:1\u201312","journal-title":"Pediatr Neurol"},{"key":"25_CR32","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","volume":"1832","author":"J Seo","year":"2013","unstructured":"Seo J, Howell MD, Singh NN, Singh RN (2013) Spinal muscular atrophy: an update on therapeutic progress. Biochim Biophys Acta 1832:2180\u20132190","journal-title":"Biochim Biophys Acta"},{"key":"25_CR33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4155\/fmc.14.63","volume":"9","author":"MD Howell","year":"2014","unstructured":"Howell MD, Singh NN, Singh RN (2014) Advances in therapeutic development for spinal muscular atrophy. Future Med Chem 9:1081\u20131099","journal-title":"Future Med Chem"},{"key":"25_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/JEN.S33122","volume":"10","author":"S Ahmad","year":"2016","unstructured":"Ahmad S, Bhatia K, Kannan A, Gangwani L (2016) Molecular mechanisms of neurodegeneration in spinal muscular atrophy. J Exp Neurosci 10:39\u201349","journal-title":"J Exp Neurosci"},{"key":"25_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1615\/CritRevEukaryotGeneExpr.v14.i4.30","volume":"14","author":"NN Singh","year":"2004","unstructured":"Singh NN, Androphy EJ, Singh RN (2004) Regulation and regulatory activities of alternative splicing of the SMN genes. Crit Rev Eukaryot Gene Expr 14:271\u2013285","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"25_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR (2008) Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 82:834\u2013848","journal-title":"Am J Hum Genet"},{"key":"25_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478:123\u2013126","journal-title":"Nature"},{"key":"25_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/mt.2011.232","volume":"20","author":"EY Osman","year":"2012","unstructured":"Osman EY, Yen PF, Lorson CL (2012) Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy. Mol Ther 20:119\u2013126","journal-title":"Mol Ther"},{"key":"25_CR39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky PN, Mitrpant C, McGovern VL, Bevan AK, Foust KD, Kaspar BK, Wilton SD, Burghes AH (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 21:1625\u20131638","journal-title":"Hum Mol Genet"},{"key":"25_CR40","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.1605731113","volume":"113","author":"SM Hammond","year":"2016","unstructured":"Hammond SM, Hazell G, Shabanpoor F, Saleh AF, Bowerman M, Sleigh JN, Meijboom KE, Zhou H, Muntoni F, Talbot K et al (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proc Natl Acad Sci USA 113:10962\u201310967","journal-title":"Proc Natl Acad Sci USA"},{"key":"25_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.omtn.2017.02.009","volume":"7","author":"V Val\u00e9rie Robin","year":"2017","unstructured":"Val\u00e9rie Robin V, Griffith G, Carter GPL, Leumann CJ, Garcia L, Goyenvalle A (2017) Efficient SMN rescue following subcutaneous Tricyclo-DNA antisense oligonucleotide treatment. Mol Ther Nucleic Acids 7:81\u201389","journal-title":"Mol Ther Nucleic Acids"},{"key":"25_CR42","doi-asserted-by":"publisher","first-page":"12214","DOI":"10.1093\/nar\/gkx824","volume":"45","author":"NN Singh","year":"2017","unstructured":"Singh NN, Del Rio-Malewski JB, Luo D et al (2017) Activation of a cryptic 5\u2032 splice site reverses the impact of pathogenic splice site mutations in the spinal muscular atrophy gene. Nucl Acids Res 45:12214. https:\/\/doi.org\/10.1093\/nar\/gkx824","journal-title":"Nucl Acids Res"},{"key":"25_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4161\/rna.4.1.4535","volume":"4","author":"RN Singh","year":"2007","unstructured":"Singh RN (2007) Evolving concepts on human SMN pre-mRNA splicing. RNA Biol 4:7\u201310","journal-title":"RNA Biol"},{"key":"25_CR44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/rna.8.4.16224","volume":"8","author":"NN Singh","year":"2011","unstructured":"Singh NN, Singh RN (2011) Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model. RNA Biol 8:600\u2013606","journal-title":"RNA Biol"},{"key":"25_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/nyas.12727","volume":"1341","author":"NN Singh","year":"2015","unstructured":"Singh NN, Lee BM, Singh RN (2015) Splicing regulation in spinal muscular atrophy by a RNA structure formed by long distance interactions. Ann N Y Acad Sci 1341:176\u2013187","journal-title":"Ann N Y Acad Sci"},{"key":"25_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.4155\/fmc.15.101","volume":"7","author":"NN Singh","year":"2015","unstructured":"Singh NN, Lee BM, DiDonato CJ, Singh RN (2015) Mechanistic principles of antisense targets for the treatment of Spinal Muscular Atrophy. Future Med Chem 7:1793\u20131808","journal-title":"Future Med Chem"},{"key":"25_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","volume":"8","author":"EW Ottesen","year":"2017","unstructured":"Ottesen EW (2017) ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy. Transl Neurosci 8:1\u20136","journal-title":"Transl Neurosci"},{"key":"25_CR48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/gt.2017.34","volume":"24","author":"NN Singh","year":"2017","unstructured":"Singh NN, Howell MD, Androphy EJ, Singh RN (2017) How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy. Gene Ther 24:520\u2013526","journal-title":"Gene Ther"},{"key":"25_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049595","volume":"7","author":"NN Singh","year":"2012","unstructured":"Singh NN, Seo J, Rahn SJ, Singh RN (2012) A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes. PLoS One 7:e49595","journal-title":"PLoS One"},{"key":"25_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.coph.2005.07.001","volume":"5","author":"A Amantana","year":"2005","unstructured":"Amantana A, Iversen PL (2005) Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers. Curr Opin Pharmacol 5:550\u2013555","journal-title":"Curr Opin Pharmacol"},{"key":"25_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2004.01.067","volume":"315","author":"NN Singh","year":"2004","unstructured":"Singh NN, Androphy EJ, Singh RN (2004) An extended inhibitory content causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun 315:381\u2013388","journal-title":"Biochem Biophys Res Commun"},{"key":"25_CR52","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1128\/MCB.00945-10","volume":"31","author":"NN Singh","year":"2011","unstructured":"Singh NN, Seo J, Ottesen EW, Shishimorova M, Bhattacharya D, Singh RN (2011) TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy. Mol Cell Biol 31:935\u2013954","journal-title":"Mol Cell Biol"},{"key":"25_CR53","first-page":"636","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Polyacrylamide gel electrophoresis. In: Nolan C (ed) Molecular cloning: a laboratory manual, vol 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 636\u2013638"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:03:46Z","timestamp":1780751026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_25","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}